https://www.reuters.com/business/healthcare-pharmaceuticals/mesoblast-soars-us-fdas-nod-review-lead-drug-candidate-2023-03-08/#:~:text=The%20brokerage%20said%20it%20expects,%241.140%20earlier%20in%20the%20session.
Brokerage Jefferies said it expects "significant" U.S. sales of the drug (nah, therapy) in fiscal 2024.
PS: I will be adding on any pull backs.
This post is not to be construed as investment advice because it is not meant to be.
- Forums
- ASX - By Stock
- Significant sales in fiscal 2024
https://www.reuters.com/business/healthcare-pharmaceuticals/mesob...
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.005(0.43%) |
Mkt cap ! $1.318B |
Open | High | Low | Value | Volume |
$1.15 | $1.17 | $1.13 | $3.743M | 3.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 78561 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 114667 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 78561 | 1.145 |
4 | 151270 | 1.140 |
4 | 53395 | 1.135 |
6 | 133073 | 1.130 |
3 | 101104 | 1.125 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 114667 | 4 |
1.165 | 45573 | 3 |
1.170 | 67634 | 7 |
1.175 | 40867 | 3 |
1.180 | 27096 | 4 |
Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |